Structures by: Burley J. C.
Total: 44
4(C14H10Cl2NO21),4(Na1),19(H2O)
4(C14H10Cl2NO21),4(Na1),19(H2O)
Journal of medicinal chemistry (2007) 50, 5 979-983
a=9.55400(10)Å b=39.4910(4)Å c=9.84120(10)Å
α=90.00° β=90.7290(10)° γ=90.00°
Ba
Ba
Journal of Solid State Chemistry (2003) 174, 96-103
a=10.1409Å b=10.1409Å c=4.3163Å
α=90° β=90° γ=120°
Nd Ba Co2 O5
BaCo2NdO5
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.96159Å b=3.93108Å c=7.5341Å
α=90° β=90° γ=90°
Nd Ba Co2 O5.31
BaCo2NdO5.31
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.9161Å b=3.9258Å c=7.5732Å
α=90° β=90° γ=90°
Nd Ba Co2 O5.51
BaCo2NdO5.51
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.9073Å b=3.9359Å c=7.5908Å
α=90° β=90° γ=90°
Nd Ba Co2 O5.30
BaCo2NdO5.3
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.9221Å b=3.9318Å c=7.5894Å
α=90° β=90° γ=90°
Nd Ba Co2 O5.52
BaCo2NdO5.52
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.8993Å b=3.9253Å c=7.5741Å
α=90° β=90° γ=90°
Nd Ba Co2 O5.5
BaCo2NdO5.5
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.89253Å b=7.84157Å c=7.57009Å
α=90° β=90° γ=90°
Nd Ba Co2 O5.69
BaCo2NdO5.69
Journal of Solid State Chemistry (2003) 170, 339-350
a=3.89935Å b=7.809Å c=7.58326Å
α=90° β=90° γ=90°
(Pd0.27 Ir0.73) O3
Ir0.73O3Pd0.27
Journal of Solid State Chemistry (2003) 174, 96-103
a=10.1409Å b=10.1409Å c=2.748Å
α=90° β=90° γ=120°
Ba14 Pd3 Ir8 O33
Ba14Ir8O33Pd3
Journal of Solid State Chemistry (2003) 174, 96-103
a=10.13982Å b=10.13982Å c=30.2178Å
α=90° β=90° γ=120°
Na0.61 (Co O2)
CoNa0.61O2
Physical Review, Serie 3. B - Condensed Matter (18,1978-) (2003) 68, 214517-1-214517-10
a=2.83176Å b=2.83176Å c=10.8431Å
α=90° β=90° γ=120°
Na0.57 (Co O2)
CoNa0.57O2
Physical Review, Serie 3. B - Condensed Matter (18,1978-) (2003) 68, 214517-1-214517-10
a=2.83287Å b=2.83287Å c=10.8969Å
α=90° β=90° γ=120°
Na0.31 (Co O2) (D2 O)1.25
CoD2.5Na0.31O3.25
Physical Review, Serie 3. B - Condensed Matter (18,1978-) (2003) 68, 214517-1-214517-10
a=2.81693Å b=2.81693Å c=19.6449Å
α=90° β=90° γ=120°
Na0.35 (Co O2) (D2 O)1.43
CoD2.86Na0.35O3.43
Physical Review, Serie 3. B - Condensed Matter (18,1978-) (2003) 68, 214517-1-214517-10
a=2.82166Å b=2.82166Å c=19.7681Å
α=90° β=90° γ=120°
La3 (Li Mn O7)
La3LiMnO7
Journal of Solid State Chemistry (2004) 177, 119-125
a=5.39596Å b=5.39596Å c=20.2297Å
α=90° β=90° γ=90°
Li2.81 Ru0.04 (Ru O4)
Li2.81O4Ru1.04
Journal of Materials Chemistry (2003) 13, 2612-2616
a=5.1057Å b=5.8545Å c=5.1062Å
α=90° β=110.039° γ=90°
Caffeine-D-tartaric acid 1/1
C8H10N4O2,C4H6O6
Chemical Communications (2006) 48
a=5.8024(1)Å b=10.0260(1)Å c=25.3674(4)Å
α=90.00° β=90.00° γ=90.00°
Theophylline L-tartaric acid 2/1
C4H6O6,2(C7H8N4O2)
Chemical Communications (2006) 48
a=8.9522(4)Å b=6.7582(5)Å c=18.8755(14)Å
α=90.0° β=100.685(4)° γ=90.0°
Theophylline DL-tartaric acid 2/1
C4H6O6,2(C7H8N4O2)
Chemical Communications (2006) 48
a=7.3102(1)Å b=8.3730(1)Å c=17.9724(3)Å
α=98.294(1)° β=99.466(1)° γ=94.527(1)°
Theophylline - DL-malic acid 1/1
C11H14N4O7
Chemical communications (Cambridge, England) (2008) 14 1644-1646
a=14.9572(8)Å b=6.07159(26)Å c=15.5163(6)Å
α=90.0° β=106.4298(17)° γ=90.0°
Theophylline - D-malic acid 1/1
C11H14N4O7
Chemical communications (Cambridge, England) (2008) 14 1644-1646
a=15.8592(8)Å b=6.07909(30)Å c=14.6549(9)Å
α=90.0° β=108.5890(19)° γ=90.0°
Glipizide/glucotrol
C21H27N5O4S1
Acta Crystallographica Section B (2005) 61, 6 710-716
a=9.1487(3)Å b=24.2873(8)Å c=5.17940(10)Å
α=93.118(3)° β=101.154(2)° γ=83.479(2)°
Sulindac
C20H17F1O3S1
Journal of Applied Crystallography (2007) 40, 2 379-381
a=12.68581(34)Å b=8.18939(20)Å c=17.7934(5)Å
α=90.0° β=106.0111(29)° γ=90.0°
Μ~2~-Aqua-bis(μ~2~-trifluoroaceto-κ^2^O,O)bis[(trifluoroacetato- κO)bis(pyridine-κN)cobalt(II)]
C28H22Co2F12N4O9
Acta Crystallographica Section E (2005) 61, 7 m1422-m1424
a=9.4211(19)Å b=10.741(2)Å c=19.185(4)Å
α=78.17(3)° β=79.00(3)° γ=76.00(3)°
Ampicillin trihydrate
C16H19N3O4S1,3H2O1
Acta Crystallographica Section E (2006) 62, 2 o797-o799
a=15.52275(16)Å b=18.9256(3)Å c=6.67375(8)Å
α=90.0° β=90.0° γ=90.0°
Pamoic Acid
C23H16O6
Acta Crystallographica Section E (2006) 62, 3 o1170-o1172
a=19.7348(7)Å b=4.78768(12)Å c=19.2544(4)Å
α=90° β=108.9622(17)° γ=90°
Dichloro[(η^5^-cyclopentadienyl)dimethyl(η^5^-3- phenylindenyl)silane]hafnium(IV)
C22H20Cl2Hf1Si1
Acta Crystallographica Section E (2007) 63, 1 m238-m240
a=10.1894(4)Å b=11.0993(4)Å c=9.6940(4)Å
α=91.974(2)° β=108.693(2)° γ=80.501(3)°
Amodiaquinium dihydrochloride dihydrate
C20H24Cl1N3O2,2Cl,2H2O
Acta Crystallographica Section E (2006) 62, 9 o4196-o4199
a=7.83868(10)Å b=26.9917(5)Å c=10.80804(18)Å
α=90° β=92.9632(13)° γ=90°
(S)-1-(methylaminocarbonyl)-3-phenylpropanaminium chloride
C10H15N2O,Cl
Acta Crystallographica Section C (2008) 64, 1 o10-o14
a=4.9758(7)Å b=8.6213(13)Å c=25.521(4)Å
α=90.00° β=90.00° γ=90.00°
(R)-5-benzyl-2,2,3-trimethyl-4-oxoimidazolidin-1-ium chloride
C13H19N2O,Cl
Acta Crystallographica Section C (2008) 64, 1 o10-o14
a=7.1167(14)Å b=19.237(4)Å c=30.370(6)Å
α=90.00° β=90.00° γ=90.00°
(S)-5-benzyl-2,2,3-trimethyl-4-oxoimidazolidin-1-ium chloride
C13H19N2O,Cl
Acta Crystallographica Section C (2008) 64, 1 o10-o14
a=7.1230(10)Å b=19.232(3)Å c=30.384(4)Å
α=90.00° β=90.00° γ=90.00°
R enantiomer
C13H19N2O,Cl,H2O
Acta Crystallographica Section C (2008) 64, 1 o10-o14
a=9.6320(19)Å b=7.0446(14)Å c=11.093(2)Å
α=90.00° β=105.82(3)° γ=90.00°
S enantiomer
C13H19N2O,Cl,H2O
Acta Crystallographica Section C (2008) 64, 1 o10-o14
a=9.6425(14)Å b=7.0517(10)Å c=11.0895(16)Å
α=90.00° β=105.796(2)° γ=90.00°
Di-μ~3~-acetato-1κ^2^O,O:2κO';2κO:3κ^2^O,O'-di-μ~2~-acetato- 1κO:2κO';2κO:3κO'-octapyridyl-1κ^3^N,2κ^2^N,3κ^3^N-tricobalt(II) bis(hexafluorophosphate)
C48H52Co3N8O82,2F6P
Acta Crystallographica Section C (2006) 62, 2 m63-m66
a=10.688(4)Å b=11.839(4)Å c=12.480(4)Å
α=98.149(5)° β=103.605(5)° γ=111.722(5)°
Di-μ~3~-acetato-1κ^2^O,O:2κO';2κO:3κ^2^O,O'-di-μ~2~-acetato- 1κO:2κO';2κO:3κO'-octapyridyl-1κ^3^N,2κ^2^N,3κ^3^N-tricobalt(II) bis(hexafluorophosphate)
C48H52Co3N8O82,2F6P
Acta Crystallographica Section C (2006) 62, 2 m63-m66
a=10.7354(6)Å b=22.1257(12)Å c=23.6103(13)Å
α=99.3800(10)° β=95.0080(10)° γ=92.2380(10)°
Sr3 ((Mn Ru) O7)
MnO7RuSr3
Chemistry of Materials (1,1989-) (2002) 14, 3976-3983
a=3.9045Å b=3.9045Å c=20.1274Å
α=90° β=90° γ=90°
Sr2 ((Mn0.5 Ru0.5) O4)
Mn0.5O4Ru0.5Sr2
Chemistry of Materials (1,1989-) (2002) 14, 3976-3983
a=3.8785Å b=3.8785Å c=12.5057Å
α=90° β=90° γ=90°
La4LiMnO8
La4LiMnO8
Journal of the American Chemical Society (2002) 124, 620-628
a=3.78709Å b=3.78709Å c=12.9561Å
α=90° β=90° γ=90°
La3 Sr Li Mn O8
La3LiMnO8Sr
Journal of the American Chemical Society (2002) 124, 620-628
a=3.80292Å b=3.80292Å c=12.6881Å
α=90° β=90° γ=90°
C11H14O5
C11H14O5
Crystal Growth & Design (2008) 8, 5 1748
a=7.5336(2)Å b=17.6877(5)Å c=8.1416(2)Å
α=90.00° β=94.8720(10)° γ=90.00°
Sparfloxamine trihydrate
C19H22F2N4O3,3(H2O)
Crystal Growth & Design (2008) 8, 1 114
a=9.1250(13)Å b=10.3010(15)Å c=11.8890(17)Å
α=90.00° β=109.207(2)° γ=90.00°
C19H22F2N4O3,3(H2O)
C19H22F2N4O3,3(H2O)
Crystal Growth & Design (2008) 8, 1 114
a=9.1533(3)Å b=10.3248(4)Å c=11.9341(4)Å
α=90.00° β=109.221(2)° γ=90.00°
C6H12O6
C6H12O6
Crystal Growth & Design (2006) 6, 10 2301
a=6.7176(2)Å b=6.7638(2)Å c=8.6217(3)Å
α=95.3550(10)° β=99.6860(10)° γ=98.8790(10)°